Carneiro-Pla Denise M, Romaguera Rita, Nadji Mehrdad, Lew John I, Solorzano Carmen C, Irvin George L
Department of Surgery, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Surgery. 2007 Dec;142(6):930-5; discussion 930-5. doi: 10.1016/j.surg.2007.09.019.
Parathyroid histopathology has been used to predict single or multiglandular disease (MGD). "Hyperplasia" implies MGD, whereas "adenoma" suggests single gland involvement. Intraoperative parathyroid hormone (PTH) monitoring (IPM) guides parathyroidectomy based on function. We sought to evaluate the accuracy of histopathology in the diagnosis of single or MGD and in predicting operative success.
We reexamined the parathyroid glands from 402 patients with sporadic primary hyperparathyroidism (SPHPT) who underwent initial IPM-guided parathyroidectomies. Operative findings and outcome were correlated with histopathology of excised glands. Operative success was eucalcemia for >or=6 months and recurrence of hypercalcemia/high PTH after successful parathyroidectomy.
Of 402 patients, 384 had 1 gland excised resulting in operative success; hyperplasia was diagnosed in 244 of the 384 (64%), with only 2 developing recurrence. Of the 384 patients, 140 (37%) had adenomas with 1 late recurrence. There were 18 patients with MGD (14 hyperplasias, 4 adenomas). There were 5 failures with hyperplasia predicting MGD. Histopathology was incorrect in predicting the number of glands involved in 249 of 402 (62%) patients, and IPM was incorrect in only 13 (3%).
Histopathology of excised abnormal parathyroid glands does not predict the secretory function of the remaining parathyroid glands left in situ. IPM guided parathyroidectomy accurately based on function alone; however, histopathology was inaccurate in predicting MGD and should not be used to guide parathyroidectomy in patients with SPHPT.
甲状旁腺组织病理学已被用于预测单发性或多腺体疾病(MGD)。“增生”意味着MGD,而“腺瘤”提示单腺体受累。术中甲状旁腺激素(PTH)监测(IPM)基于功能指导甲状旁腺切除术。我们试图评估组织病理学在诊断单发性或MGD以及预测手术成功率方面的准确性。
我们重新检查了402例接受初始IPM指导下甲状旁腺切除术的散发性原发性甲状旁腺功能亢进症(SPHPT)患者的甲状旁腺。手术结果和转归与切除腺体的组织病理学相关。手术成功定义为血钙正常≥6个月且甲状旁腺切除术后高钙血症/高PTH复发。
402例患者中,384例切除1个腺体后手术成功;384例中的244例(64%)诊断为增生,仅2例复发。384例患者中,140例(37%)有腺瘤,1例晚期复发。有18例患者为MGD(14例增生,4例腺瘤)。有5例增生预测MGD失败。402例患者中有249例(62%)组织病理学在预测受累腺体数量方面有误,而IPM仅13例(3%)有误。
切除的异常甲状旁腺的组织病理学不能预测原位保留的其余甲状旁腺的分泌功能。IPM仅基于功能准确指导甲状旁腺切除术;然而,组织病理学在预测MGD方面不准确,不应在SPHPT患者中用于指导甲状旁腺切除术。